North America Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity
North America pharmaceutical manufacturing industry market is projected to grow by 8.3% annually in the forecast period and reach $9.08 million by 2032. The growth is driven by the increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high R&D investment in pharmaceutical industry, increasing per capita healthcare expenditure, and technological advancements in manufacturing processes.
Highlighted with 83 tables and 69 figures, this 164-page report “North America Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical manufacturing industry market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Formulation, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Aenova Group
Amgen Inc.
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin Limited
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Patheon Inc.
Pfizer CentreSource
Sanofi SA
Takeda
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
Highlighted with 83 tables and 69 figures, this 164-page report “North America Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical manufacturing industry market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Formulation, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
- Tablets
- Capsules
- Injectable
- Sprays
- Suspensions
- Powders
- Other Formulations
- Oral Medicine
- Topical Medicine
- Parenteral Medicine
- Inhalations
- Other Routes of Administration
- Children & Adolescents (17 years old and below)
- Adults (18-64 years old)
- Geriatric (65 years old and above)
- Cardiovascular Diseases
- Pain
- Diabetes
- Cancer
- Respiratory Diseases
- Neurological Diseases
- Orthopedics
- Other Applications
- Branded Prescription Drugs
- Generic Prescription Drugs
- OTC Drugs
- Retail Channels
- Non-retail Channels
- In-house Facility
- Outsourced Facility
- U.S.
- Canada
- Mexico
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Aenova Group
Amgen Inc.
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin Limited
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Patheon Inc.
Pfizer CentreSource
Sanofi SA
Takeda
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY FORMULATION
3.1 Market Overview by Formulation
3.2 Tablets
3.3 Capsules
3.4 Injectable
3.5 Sprays
3.6 Suspensions
3.7 Powders
3.8 Other Formulations
4 SEGMENTATION OF NORTH AMERICA MARKET BY ROUTE OF ADMINISTRATION
4.1 Market Overview by Route of Administration
4.2 Oral Medicine
4.3 Topical Medicine
4.4 Parenteral Medicine
4.5 Inhalations
4.6 Other Routes of Administration
5 SEGMENTATION OF NORTH AMERICA MARKET BY CONSUMER GROUP
5.1 Market Overview by Consumer Group
5.2 Children & Adolescents (17 years old and below)
5.3 Adults (18-64 years old)
5.4 Geriatric (65 years old and above)
6 SEGMENTATION OF NORTH AMERICA MARKET BY THERAPEUTIC APPLICATION
6.1 Market Overview by Therapeutic Application
6.2 Cardiovascular Diseases
6.3 Pain
6.4 Diabetes
6.5 Cancer
6.6 Respiratory Diseases
6.7 Neurological Diseases
6.8 Orthopedics
6.9 Other Applications
7 SEGMENTATION OF NORTH AMERICA MARKET BY DRUG TYPE
7.1 Market Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs
8 SEGMENTATION OF NORTH AMERICA MARKET BY DISTRIBUTION CHANNEL
8.1 Market Overview by Distribution Channel
8.2 Retail Channels
8.3 Non-retail Channels
9 SEGMENTATION OF NORTH AMERICA MARKET BY MANUFACTURING FACILITY
9.1 Market Overview by Manufacturing Facility
9.2 In-house Facility
9.3 Outsourced Facility
10 NORTH AMERICA MARKET 2022-2032 BY COUNTRY
10.1 Overview of North America Market
10.2 U.S.
10.3 Canada
10.4 Mexico
11 COMPETITIVE LANDSCAPE
11.1 Overview of Key Vendors
11.2 New Product Launch, Partnership, Investment, and M&A
11.3 Company Profiles
Abbott Laboratories
Aenova Group
Amgen Inc.
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin Limited
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Patheon Inc.
Pfizer CentreSource
Sanofi SA
Takeda
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of North America Pharmaceutical Manufacturing Industry in Balanced Perspective, 2022-2032
Table 2. World Pharmaceuticals Output by Region, 2022-2025, annual percentage change
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in North America Pharmaceutical Manufacturing Industry
Table 8. North America Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 9. North America Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 10. North America Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, $ mn
Table 11. North America Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, $ mn
Table 12. North America Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 13. North America Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, $ mn
Table 14. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, $ mn
Table 15. North America Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 16. U.S. Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 17. U.S. Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 18. U.S. Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 19. Canada Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 20. Canada Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 21. Canada Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 22. Mexico Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 23. Mexico Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 24. Mexico Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 25. Abbott Laboratories: Company Snapshot
Table 26. Abbott Laboratories: Business Segmentation
Table 27. Abbott Laboratories: Product Portfolio
Table 28. Aenova Group: Company Snapshot
Table 29. Aenova Group: Business Segmentation
Table 30. Aenova Group: Revenue by Product, 2018-2019, thousand Euro
Table 31. Aenova Group: Recent Developments
Table 32. Amgen Inc.: Company Snapshot
Table 33. Amgen Inc.: Approved Drugs or Therapeutic Biologicals
Table 34. Astrazeneca: Company Snapshot
Table 35. Catalent Inc.: Company Snapshot
Table 36. Catalent Inc.: Business Segmentation in 2018
Table 37. Catalent Inc.: Product Portfolio
Table 38. Catalent Inc.: Revenue, 2018-2020, $ million
Table 39. Catalent Inc.: Revenue by Region in 2018
Table 40. Eli Lilly and Company: Company Snapshot
Table 41. Eli Lilly and Company: Pharmaceutical Brands
Table 42. F. Hoffmann-La Roche: Company Snapshot
Table 43. F. Hoffmann-La Roche: Business Segmentation
Table 44. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn
Table 45. Gilead Sciences: Company Snapshot
Table 46. Gilead Sciences: Main Products
Table 47. GlaxoSmithKline: Company Snapshot
Table 48. GlaxoSmithKline: Business Segmentation
Table 49. GlaxoSmithKline: Product Portfolio
Table 50. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 51. Johnson & Johnson: Company Snapshot
Table 52. Johnson & Johnson: Business Segments
Table 53. Lonza Group: Company Snapshot
Table 54. Lonza Group: Business Segmentation in 2018
Table 55. Lonza Group: Product Portfolio
Table 56. Lonza Group: Revenue by Region in 2018
Table 57. Lupin Limited: Company Snapshot
Table 58. Lupin Limited: Business Segmentation
Table 59. Merck & Co., Inc.: Company Snapshot
Table 60. Merck & Co., Inc.: Business Segmentation
Table 61. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 62. Novartis International AG: Company Snapshot
Table 63. Novartis International AG: Business Segmentation
Table 64. Novartis International AG: Revenue, 2017-2019, $ bn
Table 65. Novo Nordisk: Company Snapshot
Table 66. Novo Nordisk: Product Portfolio
Table 67. Patheon Inc.: Company Snapshot
Table 68. Patheon Inc.: Business Segmentation in 2018
Table 69. Patheon Inc.: Product Portfolio
Table 70. Patheon Inc.: Revenue, 2017-2019, $ billion
Table 71. Patheon Inc.: Revenue by Region in 2018
Table 72. Patheon Inc.: Recent Developments
Table 73. Pfizer CentreSource: Company Snapshot
Table 74. Pfizer CentreSource: Business Segmentation in 2018
Table 75. Pfizer CentreSource: Product Portfolio
Table 76. Pfizer CentreSource: Revenue, 2017-2019, $ billion
Table 77. Pfizer CentreSource: Revenue by Region in 2018
Table 78. Hospira, Inc. (a subsidiary of Pfizer): Company Snapshot
Table 79. Pfizer CentreSource: Recent Developments
Table 80. Sanofi: Company Snapshot
Table 81. Sanofi: Business Segmentation
Table 82. Sanofi: Revenue, 2018-2020, $ bn
Table 83. Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 1. Snapshot of North America Pharmaceutical Manufacturing Industry in Balanced Perspective, 2022-2032
Table 2. World Pharmaceuticals Output by Region, 2022-2025, annual percentage change
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in North America Pharmaceutical Manufacturing Industry
Table 8. North America Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 9. North America Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 10. North America Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, $ mn
Table 11. North America Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, $ mn
Table 12. North America Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 13. North America Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, $ mn
Table 14. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, $ mn
Table 15. North America Pharmaceutical Manufacturing Industry by Country, 2022-2032, $ mn
Table 16. U.S. Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 17. U.S. Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 18. U.S. Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 19. Canada Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 20. Canada Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 21. Canada Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 22. Mexico Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, $ mn
Table 23. Mexico Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, $ mn
Table 24. Mexico Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, $ mn
Table 25. Abbott Laboratories: Company Snapshot
Table 26. Abbott Laboratories: Business Segmentation
Table 27. Abbott Laboratories: Product Portfolio
Table 28. Aenova Group: Company Snapshot
Table 29. Aenova Group: Business Segmentation
Table 30. Aenova Group: Revenue by Product, 2018-2019, thousand Euro
Table 31. Aenova Group: Recent Developments
Table 32. Amgen Inc.: Company Snapshot
Table 33. Amgen Inc.: Approved Drugs or Therapeutic Biologicals
Table 34. Astrazeneca: Company Snapshot
Table 35. Catalent Inc.: Company Snapshot
Table 36. Catalent Inc.: Business Segmentation in 2018
Table 37. Catalent Inc.: Product Portfolio
Table 38. Catalent Inc.: Revenue, 2018-2020, $ million
Table 39. Catalent Inc.: Revenue by Region in 2018
Table 40. Eli Lilly and Company: Company Snapshot
Table 41. Eli Lilly and Company: Pharmaceutical Brands
Table 42. F. Hoffmann-La Roche: Company Snapshot
Table 43. F. Hoffmann-La Roche: Business Segmentation
Table 44. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn
Table 45. Gilead Sciences: Company Snapshot
Table 46. Gilead Sciences: Main Products
Table 47. GlaxoSmithKline: Company Snapshot
Table 48. GlaxoSmithKline: Business Segmentation
Table 49. GlaxoSmithKline: Product Portfolio
Table 50. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 51. Johnson & Johnson: Company Snapshot
Table 52. Johnson & Johnson: Business Segments
Table 53. Lonza Group: Company Snapshot
Table 54. Lonza Group: Business Segmentation in 2018
Table 55. Lonza Group: Product Portfolio
Table 56. Lonza Group: Revenue by Region in 2018
Table 57. Lupin Limited: Company Snapshot
Table 58. Lupin Limited: Business Segmentation
Table 59. Merck & Co., Inc.: Company Snapshot
Table 60. Merck & Co., Inc.: Business Segmentation
Table 61. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 62. Novartis International AG: Company Snapshot
Table 63. Novartis International AG: Business Segmentation
Table 64. Novartis International AG: Revenue, 2017-2019, $ bn
Table 65. Novo Nordisk: Company Snapshot
Table 66. Novo Nordisk: Product Portfolio
Table 67. Patheon Inc.: Company Snapshot
Table 68. Patheon Inc.: Business Segmentation in 2018
Table 69. Patheon Inc.: Product Portfolio
Table 70. Patheon Inc.: Revenue, 2017-2019, $ billion
Table 71. Patheon Inc.: Revenue by Region in 2018
Table 72. Patheon Inc.: Recent Developments
Table 73. Pfizer CentreSource: Company Snapshot
Table 74. Pfizer CentreSource: Business Segmentation in 2018
Table 75. Pfizer CentreSource: Product Portfolio
Table 76. Pfizer CentreSource: Revenue, 2017-2019, $ billion
Table 77. Pfizer CentreSource: Revenue by Region in 2018
Table 78. Hospira, Inc. (a subsidiary of Pfizer): Company Snapshot
Table 79. Pfizer CentreSource: Recent Developments
Table 80. Sanofi: Company Snapshot
Table 81. Sanofi: Business Segmentation
Table 82. Sanofi: Revenue, 2018-2020, $ bn
Table 83. Takeda Pharmaceutical Co. Ltd.: Company Snapshot
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. North America Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 5. World Healthcare Services Production, annual percentage change
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical Manufacturing Industry
Figure 8. Trends in the Approval of Cancer Therapies by FDA in the Twenty-First Century
Figure 9. Leading Causes of Death in the World, 2000 and 2019, million
Figure 10. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 11. World Population 65 and Over, % of Total Population, 1950-2060
Figure 12. Primary Restraints and Impact Factors of North America Pharmaceutical Manufacturing Industry
Figure 13. Investment Opportunity Analysis
Figure 14. Porter’s Fiver Forces Analysis of North America Pharmaceutical Manufacturing Industry
Figure 15. Breakdown of North America Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, % of Revenue
Figure 16. North America Addressable Market Cap in 2023-2032 by Formulation, Value ($ mn) and Share (%)
Figure 17. North America Pharmaceutical Manufacturing Industry by Formulation: Tablets, 2022-2032, $ mn
Figure 18. North America Pharmaceutical Manufacturing Industry by Formulation: Capsules, 2022-2032, $ mn
Figure 19. North America Pharmaceutical Manufacturing Industry by Formulation: Injectable, 2022-2032, $ mn
Figure 20. North America Pharmaceutical Manufacturing Industry by Formulation: Sprays, 2022-2032, $ mn
Figure 21. North America Pharmaceutical Manufacturing Industry by Formulation: Suspensions, 2022-2032, $ mn
Figure 22. North America Pharmaceutical Manufacturing Industry by Formulation: Powders, 2022-2032, $ mn
Figure 23. North America Pharmaceutical Manufacturing Industry by Formulation: Other Formulations, 2022-2032, $ mn
Figure 24. Breakdown of North America Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, % of Sales Revenue
Figure 25. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 26. North America Pharmaceutical Manufacturing Industry by Route of Administration: Oral Medicine, 2022-2032, $ mn
Figure 27. North America Pharmaceutical Manufacturing Industry by Route of Administration: Topical Medicine, 2022-2032, $ mn
Figure 28. North America Pharmaceutical Manufacturing Industry by Route of Administration: Parenteral Medicine, 2022-2032, $ mn
Figure 29. North America Pharmaceutical Manufacturing Industry by Route of Administration: Inhalations, 2022-2032, $ mn
Figure 30. North America Pharmaceutical Manufacturing Industry by Route of Administration: Other Routes of Administration, 2022-2032, $ mn
Figure 31. Breakdown of North America Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, % of Sales Revenue
Figure 32. North America Addressable Market Cap in 2023-2032 by Consumer Group, Value ($ mn) and Share (%)
Figure 33. North America Pharmaceutical Manufacturing Industry by Consumer Group: Children & Adolescents (17 years old and below), 2022-2032, $ mn
Figure 34. North America Pharmaceutical Manufacturing Industry by Consumer Group: Adults (18-64 years old), 2022-2032, $ mn
Figure 35. North America Pharmaceutical Manufacturing Industry by Consumer Group: Geriatric (65 years old and above), 2022-2032, $ mn
Figure 36. Breakdown of North America Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, % of Revenue
Figure 37. North America Addressable Market Cap in 2023-2032 by Therapeutic Application, Value ($ mn) and Share (%)
Figure 38. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Cardiovascular Diseases, 2022-2032, $ mn
Figure 39. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Pain, 2022-2032, $ mn
Figure 40. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Diabetes, 2022-2032, $ mn
Figure 41. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Cancer, 2022-2032, $ mn
Figure 42. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Respiratory Diseases, 2022-2032, $ mn
Figure 43. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Neurological Diseases, 2022-2032, $ mn
Figure 44. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Orthopedics, 2022-2032, $ mn
Figure 45. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Other Applications, 2022-2032, $ mn
Figure 46. Breakdown of North America Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, % of Revenue
Figure 47. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 48. North America Pharmaceutical Manufacturing Industry by Drug Type: Branded Prescription Drugs, 2022-2032, $ mn
Figure 49. North America Pharmaceutical Manufacturing Industry by Drug Type: Generic Prescription Drugs, 2022-2032, $ mn
Figure 50. North America Pharmaceutical Manufacturing Industry by Drug Type: OTC Drugs, 2022-2032, $ mn
Figure 51. Breakdown of North America Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, % of Revenue
Figure 52. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 53. North America Pharmaceutical Manufacturing Industry by Distribution Channel: Retail Channels, 2022-2032, $ mn
Figure 54. North America Pharmaceutical Manufacturing Industry by Distribution Channel: Non-retail Channels, 2022-2032, $ mn
Figure 55. Breakdown of North America Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, % of Revenue
Figure 56. North America Addressable Market Cap in 2023-2032 by Manufacturing Facility, Value ($ mn) and Share (%)
Figure 57. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility: In-house Facility, 2022-2032, $ mn
Figure 58. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility: Outsourced Facility, 2022-2032, $ mn
Figure 59. Breakdown of North America Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 60. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 61. U.S. Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 62. Sources of API Manufacturing by Product Area in U.S., as of May 2021
Figure 63. Manufacturing Locations of Essential Medicines in U.S., as of May 2021
Figure 64. Count of High-Capacity API Sites in U.S. in 2021
Figure 65. FDA-Approved API Manufacturing Sites in U.S., 2016-2021
Figure 66. Canada Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 67. Pharmaceutical Manufacturing Industry in Mexico, 2022-2032, $ mn
Figure 68. Growth Stage of North America 3D Printing Industry over the Forecast Period
Figure 69. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. North America Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 5. World Healthcare Services Production, annual percentage change
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical Manufacturing Industry
Figure 8. Trends in the Approval of Cancer Therapies by FDA in the Twenty-First Century
Figure 9. Leading Causes of Death in the World, 2000 and 2019, million
Figure 10. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 11. World Population 65 and Over, % of Total Population, 1950-2060
Figure 12. Primary Restraints and Impact Factors of North America Pharmaceutical Manufacturing Industry
Figure 13. Investment Opportunity Analysis
Figure 14. Porter’s Fiver Forces Analysis of North America Pharmaceutical Manufacturing Industry
Figure 15. Breakdown of North America Pharmaceutical Manufacturing Industry by Formulation, 2022-2032, % of Revenue
Figure 16. North America Addressable Market Cap in 2023-2032 by Formulation, Value ($ mn) and Share (%)
Figure 17. North America Pharmaceutical Manufacturing Industry by Formulation: Tablets, 2022-2032, $ mn
Figure 18. North America Pharmaceutical Manufacturing Industry by Formulation: Capsules, 2022-2032, $ mn
Figure 19. North America Pharmaceutical Manufacturing Industry by Formulation: Injectable, 2022-2032, $ mn
Figure 20. North America Pharmaceutical Manufacturing Industry by Formulation: Sprays, 2022-2032, $ mn
Figure 21. North America Pharmaceutical Manufacturing Industry by Formulation: Suspensions, 2022-2032, $ mn
Figure 22. North America Pharmaceutical Manufacturing Industry by Formulation: Powders, 2022-2032, $ mn
Figure 23. North America Pharmaceutical Manufacturing Industry by Formulation: Other Formulations, 2022-2032, $ mn
Figure 24. Breakdown of North America Pharmaceutical Manufacturing Industry by Route of Administration, 2022-2032, % of Sales Revenue
Figure 25. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 26. North America Pharmaceutical Manufacturing Industry by Route of Administration: Oral Medicine, 2022-2032, $ mn
Figure 27. North America Pharmaceutical Manufacturing Industry by Route of Administration: Topical Medicine, 2022-2032, $ mn
Figure 28. North America Pharmaceutical Manufacturing Industry by Route of Administration: Parenteral Medicine, 2022-2032, $ mn
Figure 29. North America Pharmaceutical Manufacturing Industry by Route of Administration: Inhalations, 2022-2032, $ mn
Figure 30. North America Pharmaceutical Manufacturing Industry by Route of Administration: Other Routes of Administration, 2022-2032, $ mn
Figure 31. Breakdown of North America Pharmaceutical Manufacturing Industry by Consumer Group, 2022-2032, % of Sales Revenue
Figure 32. North America Addressable Market Cap in 2023-2032 by Consumer Group, Value ($ mn) and Share (%)
Figure 33. North America Pharmaceutical Manufacturing Industry by Consumer Group: Children & Adolescents (17 years old and below), 2022-2032, $ mn
Figure 34. North America Pharmaceutical Manufacturing Industry by Consumer Group: Adults (18-64 years old), 2022-2032, $ mn
Figure 35. North America Pharmaceutical Manufacturing Industry by Consumer Group: Geriatric (65 years old and above), 2022-2032, $ mn
Figure 36. Breakdown of North America Pharmaceutical Manufacturing Industry by Therapeutic Application, 2022-2032, % of Revenue
Figure 37. North America Addressable Market Cap in 2023-2032 by Therapeutic Application, Value ($ mn) and Share (%)
Figure 38. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Cardiovascular Diseases, 2022-2032, $ mn
Figure 39. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Pain, 2022-2032, $ mn
Figure 40. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Diabetes, 2022-2032, $ mn
Figure 41. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Cancer, 2022-2032, $ mn
Figure 42. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Respiratory Diseases, 2022-2032, $ mn
Figure 43. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Neurological Diseases, 2022-2032, $ mn
Figure 44. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Orthopedics, 2022-2032, $ mn
Figure 45. North America Pharmaceutical Manufacturing Industry by Therapeutic Application: Other Applications, 2022-2032, $ mn
Figure 46. Breakdown of North America Pharmaceutical Manufacturing Industry by Drug Type, 2022-2032, % of Revenue
Figure 47. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 48. North America Pharmaceutical Manufacturing Industry by Drug Type: Branded Prescription Drugs, 2022-2032, $ mn
Figure 49. North America Pharmaceutical Manufacturing Industry by Drug Type: Generic Prescription Drugs, 2022-2032, $ mn
Figure 50. North America Pharmaceutical Manufacturing Industry by Drug Type: OTC Drugs, 2022-2032, $ mn
Figure 51. Breakdown of North America Pharmaceutical Manufacturing Industry by Distribution Channel, 2022-2032, % of Revenue
Figure 52. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 53. North America Pharmaceutical Manufacturing Industry by Distribution Channel: Retail Channels, 2022-2032, $ mn
Figure 54. North America Pharmaceutical Manufacturing Industry by Distribution Channel: Non-retail Channels, 2022-2032, $ mn
Figure 55. Breakdown of North America Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2022-2032, % of Revenue
Figure 56. North America Addressable Market Cap in 2023-2032 by Manufacturing Facility, Value ($ mn) and Share (%)
Figure 57. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility: In-house Facility, 2022-2032, $ mn
Figure 58. North America Pharmaceutical Manufacturing Industry by Manufacturing Facility: Outsourced Facility, 2022-2032, $ mn
Figure 59. Breakdown of North America Pharmaceutical Manufacturing Industry by Country, 2022 and 2032, % of Revenue
Figure 60. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 61. U.S. Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 62. Sources of API Manufacturing by Product Area in U.S., as of May 2021
Figure 63. Manufacturing Locations of Essential Medicines in U.S., as of May 2021
Figure 64. Count of High-Capacity API Sites in U.S. in 2021
Figure 65. FDA-Approved API Manufacturing Sites in U.S., 2016-2021
Figure 66. Canada Pharmaceutical Manufacturing Industry, 2022-2032, $ mn
Figure 67. Pharmaceutical Manufacturing Industry in Mexico, 2022-2032, $ mn
Figure 68. Growth Stage of North America 3D Printing Industry over the Forecast Period
Figure 69. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)
